Clinical Trial Update: OC000459 Bronchial Allergen Challenge [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of OC000459 for asthma has completed, according to the study update from Oxagen Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• OC000459

Snippet

Sponsor: Oxagen Ltd | Conditions: Bronchial Asthma | Phase 2 | Status: COMPLETED